cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1248-1257

  Linnerth, N M ^a   Greenaway, J B ^a   Petrik, J J ^a   Moorehead, R A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

CREB; Epithelial ovarian cancer; Human tissue microarray; Mouse model; RNA interference

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHOSPHORYLATION; TISSUE ARRAY ANALYSIS;

EID: 55949122454     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01177.x     Document Type: Article

References (42)

1. Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol 1994 170 : 1099 105.
2. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol 1998 25 : 281 304.
3. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001 22 : 255 88.
4. Auersperg N, Maines-Bandiera SL, Dyck HG. Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 1997 173 : 261 5.
5. Godwin AK, Testa JR, Handel LM et al. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 1992 84 : 592 601.
6. Testa JR, Getts LA, Salazar H et al. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res 1994 54 : 2778 84.
7. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971 2 : 163.
8. Gubbay O, Rae MT, McNeilly AS, Donadeu FX, Zeleznik AJ, Hillier SG. cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival. J Endocrinol 2006 191 : 275 85.
9. Blendy JA, Maldonado R. Genetic analysis of drug addiction: the role of cAMP response element binding protein. J Mol Med 1998 76 : 104 10.
10. Zhang X, Odom DT, Koo SH et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 2005 102 : 4459 64.
11. Hagiwara M, Alberts A, Brindle P et al. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 1992 70 : 105 13.
12. Ofir R, Dwarki VJ, Rashid D, Verma I M. CREB represses transcription of fos promoter: role of phosphorylation. Gene Expr 1991 1 : 55 60.
13. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002 35 : 605 23.
14. Johannessen M, Delghandi MP, Moens U. What turns CREB on? Cell Signal 2004 16 : 1211 27.
15. Shankar DB, Sakamoto KM. The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias. Leuk Lymphoma 2004 45 : 265 70.
16. Shankar DB, Cheng JC, Kinjo K et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005 7 : 351 62.
17. Zucman J, Delattre O, Desmaze C et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993 4 : 341 5.
18. Abramovitch R, Tavor E, Jacob-Hirsch J et al. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 2004 64 : 1338 46.
19. Jean D, Bar-Eli M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem 2000 212 : 19 28.
20. Jean D, Harbison M, Mcconkey D J, Ronai Z, Bar-Eli M. CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 1998 273 : 24884 90.
21. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 1995 55 : 3739 41.
22. Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood 2002 99 : 2617 9.
23. Linnerth NM, Baldwin M, Campbell C, Brown M, McGowan H, Moorehead RA. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells. Oncogene 2005 24 : 7310 9.
24. Moorehead RA, Fata JE, Johnson MB, Khokha R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Diff 2001 8 : 16 29.
25. Greenaway J, Moorehead R, Shaw P, Petrik J. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Gynecol Oncol. In press.
26. Osterholzer HO, Streibel EJ, Nicosia SV. Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 1985 33 : 247 58.
27. Sogaard M, Kjaer SK, Gayther S. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 2006 85 : 93 105.
28. Kupryjanczyk J, Bell DA, Yandell DW, Scully RE, Thor AD. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol 1994 102 : 671 6.
29. Teneriello MG, Ebina M, Linnoila RI et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 1993 53 : 3103 8.
30. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst 1994 86 : 1549 51.
31. Kohler MF, Kerns BJ, Humphrey PA, Marks JR, Bast RC Jr., Berchuck A. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 1993 81 : 643 50.
32. Chan WY, Cheung KK, Schorge JO et al. S.C. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 2000 156 : 409 17.
33. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 1997 79 : 1581 6.
34. Mandai M, Konishi I, Kuroda H et al. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. Hum Pathol 1998 29 : 34 40.
35. Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC. k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol 2001 20 : 244 51.
36. Nagaraju G, Scully R. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst) 2007 6 : 1018 31.
37. Giebler HA, Lemasson I, Nyborg JK. p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation. Mol Cell Biol 2000 20 : 4849 58.
38. Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996 384 : 641 3.
39. Van Orden K, Giebler HA, Lemasson I, Gonzales M, Nyborg JK. Binding of p53 to the KIX domain of CREB binding protein. A potential link to human T-cell leukemia virus, type I-associated leukemogenesis. J Biol Chem 1999 274 : 26321 8.
40. Stites EC, Trampont PC, Ma Z, Ravichandran KS. Network analysis of oncogenic Ras activation in cancer. Science 2007 318 : 463 7.
41. Ward R, Johnson M, Shridhar V, Van Deursen J, Couch FJ. CBP truncating mutations in ovarian cancer. J Med Genet 2005 42 : 514 8.
42. Syed V, Mukherjee K, Lyons-Weiler J et al. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone- regulated genes for ovarian cancer cells by gene profiling. Oncogene 2005 24 : 1774 87.